GlassScriptPhysician profile
Manan Shah
NPI 1194179077
$7,775.13
in general payments reported to CMS, 2019-2025
12 companies · $1,804 in 2025
The $1,804 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,885 · 2024: $4,086 · 2025: $1,804.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,047 · Food and Beverage: $1,728.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,046.87 |
| Food and Beverage | $1,728.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synthes Gmbh | $3,695.62 | 2023-2024 | |
| Medtronic, INC. | $2,226.41 | 2023-2025 | Stealthstation S8 Platform, Unid_pass, Infinity Occipitocervical Upper Thoracic System |
| Alphatec Spine, INC | $1,413.04 | 2024-2025 | Other - Miscellaneous, Invictus Open |
| Si-Bone, INC. | $164.05 | 2025 | |
| Btg International INC. | $82.07 | 2025 | |
| Kuros Biosciences USA, INC | $39.48 | 2025 | Magnetos |
| Globus Medical, INC. | $36.68 | 2025 | Xlif |
| Mml US, INC. | $30.52 | 2025 | Reactiv8 |
| Depuy Synthes Sales INC. | $29.75 | 2024 | X-Pac |
| Mid-Atlantic Surgical Systems, LLC | $27.37 | 2023 | |
| Bioventus LLC | $16.96 | 2025 | Bonescalpel & Sonicone (O.R.) |
| Nuvasive, INC. | $13.18 | 2023 | Xlif |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manan Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.